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Hélène Petit-Eisenmann, MD,§ Serge Baleynaud, MD, Yannick Jobic, MD,¶ Catherine Adams, MD,#
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Jean-Paul Quéré, MD,* Jean-Luc Monin, MD, PHD‡
Amiens, Créteil, Strasbourg, Lorient, Brest, Argenteuil, Rennes, Bordeaux, and Reims, France;
and Brussels, Belgium
Objectives This study investigated whether aortic valve replacement (AVR) is associated with improved survival in patients
with severe low-flow/low-gradient aortic stenosis (LF/LGAS) without contractile reserve (CR) on dobutamine
stress echocardiography (DSE).
Background Patients with LF/LGAS without CR have a high mortality rate with conservative therapy. The benefit of AVR in
this subset of patients remains controversial.
Methods Eighty-one consecutive patients with symptomatic calcified LF/LGAS (valve area 1 cm2, left ventricular ejection
fraction 40%, mean pressure gradient [MPG] 40 mm Hg) without CR on DSE were enrolled. Absence of CR
was defined as the absence of increase in stroke volume of 20% compared with the baseline value. Multivari-
able analysis and propensity scores were used to compare survival according to whether or not AVR was per-
formed (n  55).
Results Five-year survival was higher in AVR patients compared with medically managed patients (54  7% vs. 13 
7%, p  0.001) despite a high operative mortality of 22% (n  12). An AVR was independently associated with
lower 5-year mortality (adjusted hazard ratio from 0.16 to 5.21 varying with time [95% confidence interval:
0.12–3.16 to 0.21–8.50], p  0.00026). In 42 propensity-matched patients, 5-year survival was markedly im-
proved by AVR (65  11% vs. 11  7%, p  0.019). Associated bypass surgery (p  0.007) and MPG 20 mm
Hg (p  0.035) were independently predictive of operative mortality. Late survival after AVR (excluding operative
death) was 69  8% at 5 years.
Conclusions In patients with LF/LGAS without CR on DSE, AVR is associated with better outcome compared with medical
management. Surgery should not be withheld from this subset of patients solely on the basis of lack of CR on
DSE. (J Am Coll Cardiol 2009;53:1865–73) © 2009 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.02.026(
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Fatients with severe low-flow/low-gradient aortic stenosis
LF/LGAS) have a poor prognosis with conservative treat-
ent. In the setting of LF/LGAS, operative risk can be
tratified using dobutamine stress echocardiography (DSE)
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Contractile Reserve and Survival in LF/LGAS May 19, 2009:1865–73severe LF/LGAS and CR have
an acceptable operative risk, and
aortic valve replacement (AVR)
improves long-term survival and
functional status in most cases
(2–4).
Conversely, patients without
CR have a high operative mor-
tality, about 30% in a recent se-
ries (2). Because of this high
reported operative risk, many cli-
nicians consider that the absence
of CR on DSE represents a con-
traindication for AVR. However,
actual surgical experience in LF/
LGAS without CR on DSE is
limited, because very few data on
AVR patients have been reported
(2,3). Moreover, the prognosis
with medical management is ex-
tremely poor and a trend toward
better survival with AVR was
observed in a small series (2). We
recently reported that patients
ithout CR who survive the perioperative period improve
heir functional status in more than 90% of cases and show
n increase in left ventricular ejection fraction (LVEF) by
10% in more than 60% of cases (5). Accordingly, the
ecent American College of Cardiology/American Heart
ssociation guidelines state that some patients without CR
ould benefit from AVR (1). This European multicenter
egistry, focusing on a series of consecutive LF/LGAS
atients without CR on DSE prospectively enrolled in 10
enters between 1991 and 2006, was retrospectively ana-
yzed to compare survival after AVR and on conservative
anagement and to identify predictors of perioperative
ortality and long-term outcome.
ethods
tudy sample. Eighty-one patients with low-flow/low-
radient (mean transaortic pressure gradient [MPG] 40
m Hg, LVEF 40%) symptomatic calcified AS (aortic
alve area 1 cm2) without CR on DSE were prospectively
nrolled in 10 centers (Amiens, France; Argenteuil, France;
ordeaux, France; Brest, France; Brussels, Belgium; Créteil,
rance; Lorient, France; Reims, France; Rennes, France;
nd Strasbourg, France). The study population was divided
nto 2 groups according to whether or not aortic valve
urgery was performed (AVR group, n  55; and medical
roup, n  26). In patients treated with AVR, the severity
f AS was assessed by visual inspection of the valve at the
ime of surgery. The degree of calcification and commissural
usion was described and the stiffness of each leaflet was
ssessed in situ to confirm the severity of AS. Preliminary data
Abbreviations
and Acronyms
AS  aortic stenosis
AVR  aortic valve
replacement
CABG  coronary artery
bypass graft surgery
CAD  coronary artery
disease
CR  contractile reserve
DSE  dobutamine stress
echocardiography
EuroSCORE  European
System for Cardiac
Operative Risk Evaluation
LF/LGAS  low-flow/low-
gradient aortic stenosis
LVEF  left ventricular
ejection fraction
MPG  mean transaortic
pressure gradient
NYHA  New York Heart
Associationrom this registry were previously published (2,4–6). Forty- eour patients from these series (with extended follow-up) were
ncluded in the present report. The study was approved by local
nstitutional review boards or ethics committees, in accordance
ith institutional policies, national legal requirements, and the
evised Helsinki declaration. Informed consent was obtained
rom each patient before any study procedures.
chocardiography. All patients underwent a comprehen-
ive Doppler echocardiographic study using commercially
vailable ultrasound systems. The echocardiographic sever-
ty of aortic valve calcification was graded qualitatively as
reviously proposed by Rosenhek et al. (7), and grades 3
multiple large calcium deposits) and 4 (extensive calcifica-
ion of all cusps) were considered to be significant valve
alcification. Left ventricular outflow tract diameter was
ssumed to be constant at different flow states, and the
aseline value was used to calculate stroke volume at
aseline and during dobutamine infusion according to
tandard formulae (8). Transaortic gradients were calculated
sing the simplified Bernoulli equation (9). Aortic valve area
as calculated by the continuity equation (10). The LVEF
as calculated in all patients at inclusion. Dobutamine
chocardiographic studies were evaluated off-line in each
enter by a single experienced echocardiographer. Details of
he DSE have been described previously (2,3,5,11). Briefly,
fter baseline measurements, a dobutamine infusion was
tarted at 5 g/kg body weight/min, and titrated upward to
maximum dose of 20 g/kg/min. Absence of CR during
SE was classically defined as the absence of increase in
troke volume of 20% compared with the baseline value
2,3,5,11).
oronary angiography. Pre-operative coronary angiogra-
hy was performed in all patients. Reduction of the normal
iameter 50% was considered to define significant coro-
ary artery disease (CAD) in the left main coronary artery.
cutoff value of 70% was used for the right coronary, left
nterior descending, and circumflex arteries. Multivessel
AD was defined as the presence of significant stenoses on
or more vessels.
alculation of the European System for Cardiac Oper-
tive Risk Evaluation (EuroSCORE). The standard
uroSCORE was calculated retrospectively for each patient
sing the calculator available online (12). Risk factors
ntegrated in the EuroSCORE are patient-, cardiac-, and
peration-related factors. Patient-related factors are: age
60 years, female sex, chronic pulmonary disease, extra-
ardiac arterial disease, neurological dysfunction, previ-
us cardiac surgery, serum creatinine 200 mol/l, active
ndocarditis, and critical pre-operative state. Cardiac-
elated factors are unstable angina, reduced LVEF, recent
yocardial infarction, and pulmonary systolic pressure
60 mm Hg. Operation-related factors are: emergency
urgery other than isolated coronary artery bypass sur-
ery, thoracic aorta surgery, and surgery for post-infarct
eptal rupture.
linical decision and follow-up. Clinical decisions forach patient were left to the discretion of the referring
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May 19, 2009:1865–73 Contractile Reserve and Survival in LF/LGAShysician, who was aware of the results of individual DSE.
he end point obtained in all patients at follow-up was
urvival. The mean follow-up was 37  41 months. Peri-
perative mortality was defined as death within 30 days after
VR or before hospital discharge (2,13), and late mortality
as defined as death after the perioperative period. In
atients who underwent AVR, overall mortality combined
erioperative mortality and late mortality. New York Heart
ssociation (NYHA) functional status and LVEF during
ollow-up were assessed in 32 (74%) and 34 (79%) of the 43
atients who survived AVR (after the perioperative period),
espectively.
tatistical analysis. Continuous variables were expressed
s mean  SD and compared between groups using the
-sample Student t test or the Wilcoxon rank sum test, as
ppropriate. Categorical variables were expressed as fre-
uency percentages and compared between groups using the
hi-square test or Fisher exact test, as appropriate. Changes
n NYHA functional status over time were compared using
he McNemar test.
The imbalance in baseline variables between AVR and
edically managed patients was reduced using propensity
cores. The propensity scores for AVR were estimated for
ach of the 81 patients using a multivariable logistic model
14,15). Characteristics associated with AVR surgery on
nivariate analysis (p  0.5) were included in the multiva-
iable logistic model in a forward stepwise regression anal-
sis. A propensity score for AVR for each patient was
stimated from the resulting selected variables by maximum
ikelihood regression analysis. Goodness-of-fit, assessed by
he Hosmer-Lemeshow test (chi-square  4.7, p  0.69)
nd the discriminatory power of the model (area under the
eceiver-operating characteristic curve, C  0.73) were
cceptable. Propensity scores were used to match each
edically managed patient to a unique patient in the AVR
roup with a propensity score within 4%. Each medically
atched patient was initially matched with another patient
n the AVR group with a similar 5-digit propensity score,
nd the matched patients were removed from the database.
his procedure was repeated on the remaining patients with
uccessive matching by 4-, 3-, 2-, and 1-digit scores.
wenty-one (81%) of the 26 medically managed patients
ere successfully matched. The mean propensity score in
edically managed patients before matching was 0.63054
ompared with 0.74375 in patients who underwent AVR
p 0.002). After matching, the mean propensity score was
.65559 in non-AVR patients, comparable with that of the
VR group (0.65525, p  0.98). The distribution of
ategorical variables between the 2 groups in the matched
ohort was compared with the use of McNemar test.
ontinuous variables were compared between groups in the
atched cohort using paired t tests or Wilcoxon signed rank
ests, as appropriate.
For multivariable analysis of perioperative mortality, a
ogistic regression model including a pre-defined covariate
EuroSCORE) and variables associated with perioperative aortality on univariate analysis (p  0.10) was applied to
alculate odds ratios and 95% confidence intervals for the
et of variables independently associated with an adverse
utcome.
The association between AVR and 5-year overall mor-
ality was analyzed first in the overall cohort. Survival curves
ere generated using Kaplan-Meier survival estimates. Dif-
erences in time to death between groups were analyzed
sing a 2-sided log-rank test. The most common approach
or analyzing survival data and identifying predictors of out-
ome is the Cox model, which assumes constant hazard ratios
hroughout a subject’s time course (proportional hazards as-
umption). However, this assumption probably does not hold
fter cardiac surgery, because the hazard ratio for death will
ikely decrease after the perioperative period (6). Gray’s
iecewise-constant time-varying coefficients survival model
s an extension of the Cox proportional hazards model that
llows the regression coefficients to change over different
ime intervals (16). It has, therefore, the ability to estimate
ow the hazards of individual risk factors change over time
6,16) and may be better suited for modeling survival after
ardiac surgery. We used single-variable Gray models to
dentify variables associated with 5-year overall mortality.
hese models were fitted using 5 intervals: the perioperative
eriod and 4 subsequent time intervals, each containing
pproximately equal numbers of deaths (16). The duration
f each interval was determined automatically, based on
hen the events occur. Gray’s model has its own test of
roportionality, a value of p  0.10 assuming nonpropor-
ionality. In the multivariable model we included a pre-
efined covariate (EuroSCORE) and variables associated
ith overall mortality on univariate analysis (p  0.10). For
ach variable, a specific hazard ratio for each of the 5 time
ntervals was found. For proportional variables, the mean of
hese values of hazard ratios were reported with the mean of
5% confidence interval limits. For nonproportional vari-
bles, the range from minimum to maximum hazard ratio is
eported. The overall significance of the nonproportional
ariables is given by the p value. In the matched cohort,
aplan-Meier survival curves were estimated for patients
ho underwent AVR and for medically managed patients.
he survival curves of matched patients were compared
ccording to methods appropriate for matched data (17).
or all tests, a value of p  0.05 was considered statistically
ignificant. All p values are results of 2-tailed tests. Statis-
ical analysis was performed with SPSS 13.0 (SPSS Inc.,
hicago, Illinois), and the R Project for Statistical Com-
uting (release 2.8.1, CICT, Toulouse, France). Gray’s
rogram, written for R, is available from the author’s
ebsite (18).
esults
aseline characteristics of the study population. The
tudy included 81 patients (22 women, 59 men) with a mean
ge of 71  10 years, mean aortic valve area of 0.75  0.16
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Contractile Reserve and Survival in LF/LGAS May 19, 2009:1865–73m2, mean indexed aortic valve area of 0.40 0.09 cm2/m2,
ean cardiac index of 2.29 0.56 l/min/m2, MPG of 28
mm Hg, and mean LVEF of 29  7%. Significant valve
alcification was observed at echocardiography in all pa-
ients (7). All patients complained of dyspnea, and 67
atients (83%) were classified in NYHA functional class III
o IV. Seven patients had associated angina, and 2 had a
istory of syncope. Forty-two patients (52%) had significant
AD; multivessel CAD was identified in 33 patients (41%).
ighteen patients (22%) had a history of myocardial infarc-
ion, and 1 patient (1.2%) had previously undergone coro-
ary artery bypass graft surgery (CABG). Baseline charac-
eristics of the study population are presented in Table 1.
he severity of AS was confirmed by the surgeon in all AVR
atients except for 1 patient, in whom the surgeon consid-
red AS to be moderate.
Compared with the medically managed group (n  26),
atients who underwent AVR (n  55) were younger (age
0  11 years vs. 75  8 years), had a lower frequency of
hronic renal failure, and tended to more frequently suffer
rom diabetes mellitus. The EuroSCORE was similar in
VR patients and medically managed patients. Mean
VEF was comparable between patients operated for AVR
nd medically managed patients (29 7% vs. 27 7%, p
.14). AVR patients had higher MPG (29  7 mm Hg vs.
4  6 mm Hg, p  0.001). Forty-six percent (n  25) of
he 55 AVR patients received a mechanical prosthesis, and
4% (n  30) received a bioprosthesis.
utcome. Forty-six deaths were recorded during follow-
p. The 5-year overall survival of the study population was
linical Characteristics of the Overall Population and Comparison BVR and Medi ally Managed Pati nts Before and After the Matchi
Table 1 Clinical Characteristics of the Overall Population and CAVR and Medically Managed Patients Before and Afte
Before Match (n 
Variable Overall (n  81) No AVR (n  26)
Age (yrs) 71 10 75 8
Male sex 59 (73) 16 (62)
Body mass index (kg/m2) 25 3 24 3
Hypertension 19 (24) 5 (19)
Chronic renal failure 12 (15) 7 (27)
Diabetes mellitus 12 (15) 1 (4)
COPD 12 (15) 3 (12)
History of cancer 7 (9) 3 (12)
EuroSCORE 10 27 (33) 11 (42)
Coronary artery disease 42 (52) 16 (62)
Prior myocardial infarction 18 (22) 8 (31)
MVD 33 (41) 12 (46)
Congestive heart failure 67 (83) 21 (81)
Aortic valve area (cm2) 0.75 0.16 0.74 0.18
Left ventricular outflow tract (cm) 2.1 0.2 2.1 0.2
LVEF (%) 29 7 27 7
MPG (mm Hg) 28 7 24 6
MPG 20 mm Hg 13 (16) 7 (27)
Systolic PAP (mm Hg) 48 13 51 10
alues are n (%) or mean  SD.
AVR aortic valve replacement; COPD chronic obstructive pulmonary disease; EuroSCORE Europe
ean transaortic pressure gradient; MVD  multivessel coronary artery disease; no AVR  medically ma1 6% (Fig. 1). Survival was significantly lower in patients
ith significant CAD, MPG 20 mm Hg, and medically
anaged patients (Table 2). Five-year overall survival was
5  10% in patients with MPG 20 mm Hg versus 46 
% in patients with MPG20 mm Hg (Fig. 2A), and 32
% in patients with significant CAD versus 51  8% in
atients without CAD (Fig. 2B).
enocedure
arison Between
Matching Procedure
After Match (n  42)
R (n  55) p Value No AVR (n  21) AVR (n  21) p Value
70 11 0.03 74 8 73 10 0.74
43 (78) 0.11 14 (67) 16 (76) 0.73
25 3 0.78 25 4 24 3 0.71
14 (26) 0.53 3 (14) 5 (24) 0.69
5 (9) 0.04 6 (29) 4 (19) 0.73
11 (20) 0.09 1 (5) 4 (19) 0.22
9 (16) 0.56 3 (14) 3 (14) 1.00
4 (7) 0.67 2 (10) 1 (5) 1.00
26 (47) 0.21 8 (38) 9 (43) 0.85
10 (18) 0.23 11 (52) 12 (57) 1.00
21 (38) 0.20 7 (33) 4 (19) 0.45
46 (84) 0.49 7 (33) 8 (38) 1.00
16 (29) 0.75 16 (76) 17 (81) 1.00
74 0.15 0.89 0.74 0.18 0.75 0.18 0.82
.1 0.1 0.58 2.1 0.2 2.0 0.1 0.70
29 7 0.14 27 6 26 7 0.50
29 7 0.001 25 5 25 4 0.74
6 (11) 0.10 5 (24) 5 (24) 1.00
47 14 0.53 49 10 46 15 0.55
Figure 1 Probability of Survival
in LF/LGAS Patients Without CR on DSE
Kaplan-Meier estimate of the probability of survival of the total study popula-
tion (n  81). CR  contractile reserve; DSE  dobutamine stress echocardi-
ography; LF/LGAS  low-flow/low-gradient aortic stenosis.etweng Pr
omp
r the
83)
AV
0.
2an System for Cardiac Operative Risk Evaluation; LVEF left ventricular ejection fraction; MPG
naged patients; PAP  pulmonary artery pressure.
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May 19, 2009:1865–73 Contractile Reserve and Survival in LF/LGASperative mortality and post-operative outcome. Among
he 55 patients who underwent AVR, 12 died during the
erioperative period. Perioperative mortality was therefore
2%. The main cause of perioperative mortality was cardio-
enic shock in 10 patients (83.4%). One patient died from
ultiorgan failure, and another died from septic shock. On
nivariate analysis, CABG associated with AVR (p 
redictors of Overall Mortality on Univariate Analysis in the 81 Patith Low-Flow/Low-Gradient A rtic Stenosis Without Contractile R
Table 2 Predictors of Overall Mortality on Univariate Analysis iWith Low-Flow/Low-Gradient Aortic Stenosis Without C
Variable Alive (n  35) Dead (n  46
Age (yrs) 71 9 72 11
Male sex 25 (71) 34 (74)
Body mass index (kg/m2) 25 3 24 3
Hypertension 5 (14) 14 (30)
Chronic renal failure 3 (9) 9 (20)
Diabetes mellitus 6 (17) 6 (13)
COPD 4 (11) 8 (17)
History of cancer 4 (11) 3 (7)
EuroSCORE 10 9 (26) 18 (39)
Coronary artery disease 14 (40) 28 (61)
Prior myocardial infarction 7 (20) 11 (24)
MVD 12 (34) 21 (46)
CABG 5 (14) 11 (24)
Congestive heart failure 28 (80) 39 (85)
Aortic valve area (cm2) 0.73 0.16 0.76 0.15
Left ventricular outflow tract (cm) 2.0 0.2 2.1 0.2
Left ventricular ejection fraction (%) 30 6 28 8
MPG (mm Hg) 30 6 26 7
MPG 20 mm Hg 2 (6) 11 (24)
Systolic PAP (mm Hg) 47 15 49 11
Aortic valve replacement 31 (89) 24 (52)
alues are n (%) or mean  SD. *Nonproportionality was tested using the Schoenfeld residuals (p
CABG  coronary artery bypass graft surgery; other abbreviations as in Table 1.
Figure 2 Influence of MPG and CAD on Survival in LF/LGAS Pa
Kaplan-Meier estimates of the probability of survival of the total population (n  8
transvalvular gradient (MPG) 20 and 20 mm Hg, and (B) presence of significan.001), MPG 20 mm Hg (p  0.01), longer cardiopul-
onary bypass time (163  54 min vs. 101  51 min, p 
.003), and longer aortic cross-clamp time (116  37 min
s. 70  36 min, p  0.001) were associated with increased
erioperative mortality. Associated CABG (odds ratio: 9.7,
5% confidence interval [CI]: 1.9 to 49.9, p  0.007) and
PG 20 mm Hg (odds ratio: 10.0, 95% CI: 1.2 to 84.9,
e
81 Patients
actile Reserve
Association With Mortality
Cox p Value Gray p Value p Value for Nonproportionality*
0.34 0.15 0.08
0.81 0.70 0.20
0.66 0.19 0.07
0.05 0.17 0.90
0.23 0.07 0.10
0.54 0.61 0.66
0.27 0.51 0.66
0.37 0.72 0.63
0.21 0.52 0.81
0.03 0.04 0.50
0.55 0.86 0.87
0.11 0.14 0.29
0.07 0.01 0.03
0.83 0.18 0.06
0.48 0.71 0.68
0.49 0.67 0.68
0.16 0.56 0.82
0.009 0.0006 0.003
0.003 0.0015 0.06
0.90 0.78 0.59
0.001 0.000003 0.00007
0 assuming nonproportionality).
s Without CR on DSE
ording to: (A) mean pre-operative
nary artery disease (CAD). Abbreviations as in Figure 1.ientsserv
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Contractile Reserve and Survival in LF/LGAS May 19, 2009:1865–73 0.035) were the 2 independent predictors of perioper-
tive mortality. Operative mortality of the subgroup of
atients with MPG 20 mm Hg was 67% (n  4 of 6)
ompared with 16% (n  8 of 49) in patients with MPG
20 mm Hg. Patients in whom CABG was performed at
he time of AVR had an operative mortality of 53% (n  8
f 15) compared with 10% (n  4 of 40) for patients in
hom associated CABG was not performed at the time
f AVR. Late survival (excluding perioperative mortality)
f patients in whom AVR was performed was 69  8% at
years (Fig. 3).
Among AVR patients (n  55), 5-year overall mortality
as significantly higher in patients with MPG20 mm Hg
Figure 3 Late Survival in Operated
LF/LGAS Patients Without CR on DSE
Kaplan-Meier estimate of the probability of late survival (excluding perioperative
mortality) of aortic valve replacement patients (n  55). Abbreviations as in Figure 1.
Figure 4 Prognostic Impact of AVR in LF/LGAS Patients Witho
Kaplan-Meier estimates of the probability of survival according to whether aortic va
was performed: (A) total population (n  81), and (B) matched patients (n  42)83  15% vs. 41  7%, p  0.003) and in patients with
AD (60  10% vs. 33  9%, p  0.02). Among the 32
VR patients in whom functional status was assessed after
VR, 81% (n  26) were in NYHA functional class III to
V pre-operatively, compared with 9.4% (n  3) post-
peratively (p  0.001). In the 34 patients who had
ost-operative LVEF assessment, LVEF improved signifi-
antly, from 31.2  6.2% pre-operatively to 46.6  10.2%
fter AVR (p  0.001).
VR versus medical management. During the 5-year
ollow-up, 34 deaths occurred after the index hospital
ischarge. In almost 80% of cases (n  27), the cause of
eath was cardiovascular (pump failure in 18 patients,
udden cardiac death in 7, and vascular noncardiac death in
cases). Six patients (17%) died of noncardiovascular causes
fter discharge. In 1 patient (3%), the cause of death
emained unknown. The 5-year overall survival in patients
perated for AVR was 54  7%, significantly higher than
hat of medically managed patients (13  7%, p  0.001)
Fig. 4A). On univariate Gray’s piecewise-constant time-
arying coefficients analysis, AVR was associated with a
ignificantly lower risk of 5-year mortality (p  0.000003)
Table 2). On multivariable analysis, after adjustment for
uroSCORE (including age) and variables associated with
-year mortality on univariate analysis, AVR was associated
ith a lower subsequent mortality (adjusted hazard ratio:
.16 to 5.21 varying with time, 95% CI: 0.12–3.16 to
.21–8.50, p 0.00026). The impact of aortic valve surgery
n survival was not constant over time (Fig. 5). The excess
erioperative mortality related to AVR was outweighed by
he significant and sustained survival benefit of AVR pa-
ients throughout the 5-year follow-up. Both MPG 20
m Hg (adjusted hazard ratio: 0.57 to 11.25 varying with
ime, 95% CI: 0.12–2.48 to 0.83–14.73, p  0.012) and
on DSE
placement (AVR)
viations as in Figure 3.ut CR
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May 19, 2009:1865–73 Contractile Reserve and Survival in LF/LGASignificant CAD (adjusted hazard ratio: 1.30, 95% CI: 1.08
o 2.07, p  0.03) were independently predictive of 5-year
verall mortality. By propensity scores matching, 21 of the
6 patients not treated by AVR were successfully matched.
fter matching, no difference in baseline variables was
bserved between the 2 groups (Table 1). In the 42 matched
atients, 5-year survival was 65  11% for the AVR group
nd 11  7% for medically managed patients (Fig. 4B). In
he matched cohort, AVR remained associated with a
ignificant survival benefit during the 5-year follow-up
p  0.019).
iscussion
he present study is derived from an international multi-
enter registry of LF/LGAS and outlines the prognostic
mplications of surgery in LF/LGAS patients without CR
n DSE. These results show that LF/LGAS without CR
n DSE has a catastrophic long-term outcome on con-
ervative management with a 5-year mortality as high as
7%, compared with a 5-year mortality of 31% in patients
perated for AVR. Using multivariable analysis and pro-
ensity scores to reduce the imbalance in baseline covariates
etween medically managed patients and AVR patients,
urgery was shown to be associated with a marked reduction
f long-term mortality. Therefore, despite high operative
ortality (22%), surgery should not be contraindicated for
F/LGAS patients on the sole basis of absence of CR on
SE because these patients present unacceptably high
Figure 5
Nonproportionality of the
Effect of Aortic Valve Replacement
on Mortality According to the Gray Model
The solid line represents the evolution of the hazard ratio for
mortality over time, and the dashed lines represent 95% confidence intervals.ortality on medical management and have an acceptable long-term outcome after AVR with significant functional
nd LVEF improvement (5).
In selected patients with LF/LGAS, AVR is associated
ith a dramatic long-term survival benefit compared with
edical management (2,19,20). Moreover, patients who
urvive surgery usually improve their functional status, and
n more than 80% of cases LVEF increases by at least 10%
ost-operatively (5). Recent studies conducted in LF/
GAS have reported operative mortality rates between 8%
nd 16% (2–4,20). We have recently reported that operative
ortality in LF/LGAS has significantly decreased to ap-
roximately 10% over the last 5 years (4). Operative mor-
ality and poor long-term outcome are mainly related to
lder age, comorbidities, low MPG (20 mm Hg), severe
ssociated CAD, history of myocardial infarction, and
bsence of CR on DSE (2,4,13,20).
Currently DSE is used to stratify operative risk in
atients with LF/LGAS (2,3,19,21). Patients with severe
F/LGAS and CR on DSE have an acceptable operative
ortality of 5% to 7% (2,3), and AVR improves long-term
urvival and functional status in most cases (2,3). European
uidelines recommend surgery for this group of patients
19). Patients who do not experience a 20% increase in
troke volume on DSE are considered to have LF/LGAS
ithout CR (2,3,5,11). In this setting, the assessment of the
rue severity of the AS remains a difficult issue. In our
xperience, pseudosevere AS (mild to moderate AS associ-
ted with an alternative cause of left ventricular dysfunction)
s relatively rare, being observed in only 5% of LF/LGAS
atients (2), and severe aortic valve calcification on echo-
ardiography, fluoroscopy, or computed tomography is a
aluable element in favor of significant AS (7,22). B-type
atriuretic peptide may also be useful for identifying true
evere LF/LGAS (23).
The management of LF/LGAS without CR is difficult
nd controversial because few studies have included patients
ithout CR (2,3,11,21). Patients with LF/LGAS but with-
ut CR on DSE have been reported to present a high
perative risk with an operative mortality of about 30%
2,5). In the present study, the operative mortality was 22%.
he subgroup with MPG 20 mm Hg had dramatically
igher operative mortality. The absence of CR on DSE
ould therefore be interpreted as a contraindication for
urgery, especially in patients with MPG 20 mm Hg.
owever, the limited available data portend a grim outcome
or medically managed LF/LGAS patients without CR
2,3,21). Based on a small preliminary series, we have
reviously reported that medically managed patients with-
ut CR have a 2-fold higher 2-year mortality rate compared
ith patients in whom AVR is performed, but this differ-
nce was not significant (2). Moreover, the majority of
atients without CR on DSE who survive AVR have a
ignificant increase in post-operative LVEF and improve-
ent in functional status (5), a finding that was confirmed
y the present study. Therefore, the main determinant for
ow pre-operative LVEF in these patients without CR on
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Contractile Reserve and Survival in LF/LGAS May 19, 2009:1865–73SE who survive AVR is probably an afterload mismatch
hat cannot be corrected by inotropic stimulation with
obutamine infusion. Consequently, the lack of CR on
SE is not systematically related to irreversible left ventric-
lar dysfunction. The results of the present study suggest
hat a conservative therapeutic strategy is not an option for
hese severely diseased patients because the 5-year survival
f the medically managed group is extremely poor. Despite
high operative mortality, the group in which AVR was
erformed had a better outcome, and the late survival of
VR patients was acceptable. To reduce the impact of
aseline characteristics, a propensity score analysis was
erformed and each medically managed patient was
atched to a unique AVR patient. After matching, AVR
as still associated with an impressive survival benefit.
tudy strengths and limitations. The number of patients
n this cohort is relatively small, but this is the largest study
ocusing on LF/LGAS without CR on DSE. The decision
o perform AVR was left to the referring physician. Because
f the small number of perioperative fatal events, the
ultivariable analysis on perioperative mortality is overfit-
ed. The potential inclusion of patients with moderate AS
nd severe left ventricular dysfunction with exhausted CR
n DSE represents a limitation. Nevertheless, the uniform
resence of severe aortic valve calcification on fluoroscopy
nd/or echocardiography supports the assumption that AS
as severe in almost every case (22). Computed tomogra-
hy, which offers the advantage of objective quantification
f calcification, was not performed in this study (22).
lthough the distinction of moderate and severe AS by
urgical judgment may be questionable, the severity of AS
as confirmed by the surgeon in all but 1 of the patients in
hom AVR was performed. The outcome of medically
anaged patients if they had been treated by AVR remains
nknown. Although the small number of patients limits the
bility of this study to draw definitive conclusions on the
anagement of this high-risk subset of LF/LGAS patients,
ur results provide evidence that caution is warranted when
herapeutic decisions in LF/LGAS are made and call for
urther rigorous prospective studies to evaluate the implica-
ions of AVR in the management of LF/LGAS patients.
lthough the propensity analysis emphasized that AVR
ignificantly improves long-term survival in patients with
F/LGAS without CR, the association between AVR and
utcome might have been influenced by factors beyond the
ocumented variables.
In our study, B-type natriuretic peptide was not system-
tically determined and its potential role was therefore
ot analyzed (23). A history of myocardial infarction was
ot associated with poorer outcome in our study. How-
ver, the extent of scar and the amount of viable myo-
ardium have certainly an important role in the patho-
hysiology of the contractile dysfunction in LF/LGAS and
hould be investigated in future studies. This study used the
tandard EuroSCORE to assess the risk for cardiac surgery.
he EuroSCORE has a reasonable predictive ability foroth coronary and valve surgery, but may have limited
redicted capacity for patients at high risk and for
ombined valvular and coronary surgery (24).
linical implications. This multicenter study shows that
he long-term outcome of calcified LF/LGAS without CR
n DSE is extremely poor when patients are treated
onservatively. Despite a high operative mortality of 22%,
VR was clearly associated with improved survival in this
ategory of patients. These results suggest that AVR could
e the treatment of choice for most patients with calcified
F/LGAS without CR on DSE. The decision not to
erform surgery in calcified LF/LGAS should be made case
y case, taking into account risk factors resulting in a very
igh operative risk. In our opinion, AVR should be consid-
red in patients with calcified LF/LGAS without CR on
SE when MPG is 20 mm Hg, and in the absence of
xcessive comorbidities or severe CAD with large scarring
aused by extensive myocardial infarction. Heart transplan-
ation should also be considered in eligible patients as an
lternative to AVR. Percutaneous or transapical AVR could
lso possibly represent a valuable alternative to classic AVR
n these patients at high risk for surgical AVR. Actually, in
he near future, these new procedures may considerably
hange the therapeutic strategies in patients with calcified
F/LGAS without CR. This issue will need to be addressed
n further studies.
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